Á¦¸ñ
|
Á¦6ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
|
ÀÛ¼ºÀÚ
|
KCFKOREA
|
ÀÛ¼ºÀÏÀÚ
|
2019-04-09
|
Á¦6ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ °³ÃÖ Àå¼Ò : »ñÆ÷·Î½ÃÁÖÃÖ : AHCC ¿¬±¸È¸ ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷ÈÇÐ ¸Å³â ÀϺ» »ñÆ÷·Î¿¡¼ ¿¸®´Â AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ,¿ÃÇصµ Á¦6ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ°¡ °³ÃֵǾú½À´Ï´Ù.¿ÃÇØ °¿¬Àº AHCCÀÇ ±âº»ÀûÀÎ ±â´É¿¡ ÃÊÁ¡À» ¸ÂÃçNK ¼¼Æ÷ È°¼ºÈ·Î ¸é¿ª·ÂÀ» ÁõÁø½ÃÅ°´Â AHCCÀÇ ±âÃÊ ±âÀüÀ» È°¿ëÇÑ °¿¬ÀÌ ¸¹¾Ò½À´Ï´Ù. General Lecture¡°Effect of AHCC on diabetes induced by streptozotocin (STZ) in mice -2¡± Masatoshi Yamazaki, et al. £¨Teikyo University, Japan£© ¡°Suppressive effect of AHCC on thymocyte apoptosis induced by dexamethasone in rat¡± Shigeru Matsuzaki, et al. £¨Dokkyo University School of Medicine, Japan£© ¡°Reductive effect of AHCC on the side effect induced by anticancer drugs: Liver injury¡± Buxiang Sun, et al. £¨Amino Up Chemical Co., Ltd., Japan£© ¡°Changes of mouse omental milky spots by intraperitoneal injection of AHCC¡± Nobuo Takemori, et al. £¨Asahikawa Kosei Hospital, Japan£© ¡°Expression of cytokines by AHCC fractions in normal and tumor bearing mice¡± Lan Yuan, et al. £¨Amino Up Chemical Co., Ltd., Japan£© ¡°Cancer therapy using AHCC in Oasis Hospital, Mexico¡± Francisco Contoreras, et al. £¨Oasis Hospital, Mexico£© ¡°AHCC treatment for the carcinomatous peritonitis patients¡± Kanji Takahashi, et al. £¨Kansai Medical University, Japan£© ¡°The experience using AHCC to treat gastrointestinal cancers¡± Yusai Kawaguchi, et al. £¨Kansai Medical University, Japan£© ¡°The new immunothrapy using Human natural (Hn) IL-12 inducer¡± Akikuni Yagita, et al. £¨Kinki University, Japan£© ¡°Dose dependency of AHCC on mallignant disease patients¡± Mitsuaki Iwamoto, et al. £¨Enzankai Hospital, Japan£© ¡°Effect of AHCC as a complementary therapy on prognosis of postoperative hepatocellular carcinoma patients¡± Youichi Matsui, et al. £¨Kansai Medical University, Japan£©
|
Á¶È¸¼ö
|
201
|
|